Journal article icon

Journal article

New approaches for the treatment of diabetic macular oedema: recommendations by an expert panel.

Abstract:

The current standard therapy for patients with diabetic macular oedema (DME)--focal/grid laser photocoagulation--usually does not improve impaired vision, and many patients lose vision despite laser therapy. Recent approval of ranibizumab by the European Medicines Agency to treat visual impairment due to DME fulfils the previously unmet medical need for a treatment that can improve visual acuity (VA) in these patients. We reviewed 1- and 2-year clinical trial findings for ranibizumab used as ...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1038/eye.2011.337

Authors


Expand authors...
Journal:
Eye (London, England)
Volume:
26
Issue:
4
Pages:
485-493
Publication date:
2012-04-01
DOI:
EISSN:
1476-5454
ISSN:
0950-222X
Source identifiers:
325823
Language:
English
Keywords:
Pubs id:
pubs:325823
UUID:
uuid:3d223b8b-6726-4393-9633-c20cc3399fcc
Local pid:
pubs:325823
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP